🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05873387
Recruiting Observational

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

NCT05873387 · tracked via the Priya Life Science USA tracker
Sponsor
Eko Devices, Inc.
Phase
Observational
Started
2023-07-12
Last updated
2026-08-24

Condition(s) studied

Pulmonary Hypertension

Investigational drug(s) / intervention(s)

Use of Eko DUO stethoscope (paired ECG/PCG)

Use of Eko DUO stethoscope (paired ECG/PCG): Auscultation of heart sounds using electronic stethoscope

Study summary

The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patients, ages \>18 years, referred for complete 2-dimensional echocardiography or right heart catheterization will be screened for inclusion. Exclusion Criteria: * Patients undergoing limited echocardiography * Intubated patients

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Rhode Island Hospital Providence Rhode Island Suspended
The Miriam Hospital Providence Rhode Island Suspended
Providence VA Medical Center Providence Rhode Island Recruiting

More Eko Devices, Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05873387 on ClinicalTrials.gov ↗ ← All trials in the USA